Mutation-aware drug-repurposing triage
Targeted cancer drugs fail by resistance — the tumor changes shape and the drug no longer binds. Deciding what to test next, or whether an already-approved drug could be repurposed, means expensive, slow wet-lab screening. This tool is the fast first pass: for a tumor's driver mutation it scores a panel of approved drugs against the wild-type and mutant protein and sorts them into what to stop, what still binds, and what's worth testing — with the uncertainty stated, before you spend a day at the bench.
The verdict
Does it hold up?
The evidence — wild-type → mutant binding shift
Claude's read
Run it on your own tumor
You are not limited to these examples. The docking is the only GPU-heavy step, and it runs on your hardware (a lab cluster, or a rented cloud GPU). Give the tool your tumor's wild-type and mutant structures, run the documented pipeline, add one config entry, and the same triage and this page work on your genotype.
cluster/ against the drug panel.config/mutations.json mapping the label to the structures.// config/mutations.json — add your genotype, no code changes
"EGFR L747_P753delinsS": {
"target": "EGFR", "wt": "3POZ", "mut": "YOUR_PDB",
"note": "exon-19 deletion; sensitizing"
}
Full walkthrough: docs/bring_your_own_tumor.md. The GPU run stays on your side — the tool ingests the scores it produces.